Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Study of Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

NCT05649956 is registered in ClinicalTrials.gov with GOG Foundation as lead sponsor.

NCT NCT05649956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05649956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Study of Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
Lead sponsor
GOG Foundation
Phase
Phase 2
Overall status
Recruiting
Start date
July 17, 2024
Completion date
July 30, 2029
Enrollment
40 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

uterine leiomyosarcoma